The ubiquitin proteasome system in human cardiomyopathies and heart failure

Sharlene M Day1

  • 1Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI, USA. sday@umich.edu

Insights

Protein quality control, managed by the ubiquitin proteasome system (UPS), is vital for heart health. UPS dysfunction is linked to cardiac diseases, particularly in human cardiomyopathies, requiring further investigation.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Proteostasis

Background:

  • The ubiquitin proteasome system (UPS) is essential for maintaining protein quality control.
  • Dysfunction of the UPS is increasingly implicated in various cardiac diseases, including heart failure and cardiomyopathies.
  • The complex regulation of the cardiac UPS and its role in disease pathophysiology are not fully understood.

Purpose of the Study:

  • To review the role of UPS dysfunction in human dilated and hypertrophic cardiomyopathies.
  • To highlight current knowledge gaps and suggest future research directions in cardiac UPS research.

Main Methods:

  • Review of existing literature on UPS dysfunction in human cardiomyopathies.
  • Focus on studies utilizing human heart tissue to establish clinical relevance.
  • Analysis of experimental findings from animal models and human studies.

Main Results:

  • UPS dysfunction is a significant factor in the development of dilated and hypertrophic cardiomyopathies.
  • Human heart tissue studies are crucial for validating experimental findings and generating new hypotheses.
  • The complexity of cardiac UPS regulation presents numerous avenues for further research.

Conclusions:

  • UPS dysfunction is a key contributor to human cardiomyopathies.
  • Further research into the cardiac UPS is warranted, particularly using human tissue studies.
  • Understanding the cardiac UPS offers potential therapeutic targets for heart disease.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...